2013
DOI: 10.1074/jbc.m113.457002
|View full text |Cite
|
Sign up to set email alerts
|

Chloroquine Binding Reveals Flavin Redox Switch Function of Quinone Reductase 2

Abstract: Background:The flavoenzyme quinone reductase 2 (NQO2) has an unknown cellular function and binds many drugs and bioactive molecules. Results: Reduction of FAD and binding of chloroquine cause a change in NQO2 conformation. Conclusion: NQO2 functions as a chloroquine-dependent flavin redox switch. Significance: A flavin redox switch function of NQO2 could explain off-target effects of chloroquine and other bioactive molecules.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
53
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(55 citation statements)
references
References 52 publications
2
53
0
Order By: Relevance
“…Thus, the decrease in the space group symmetry of the OXA-58 crystal soaked in the solution of either compound must be presumed to result from their binding to the enzyme (whether covalently or noncovalently), effecting a structural change to the protein. An example of ligand binding reducing the space group symmetry of the protein crystal, which is linked to the induction of conformational changes in the protein structure, is found in the literature: the flavin adenine dinucleotide (FAD)-linked quinone reductase 2 enzyme gave a reduction in the space group symmetry and structural change upon the binding of chloroquinone (35).…”
Section: Resultsmentioning
confidence: 99%
“…Thus, the decrease in the space group symmetry of the OXA-58 crystal soaked in the solution of either compound must be presumed to result from their binding to the enzyme (whether covalently or noncovalently), effecting a structural change to the protein. An example of ligand binding reducing the space group symmetry of the protein crystal, which is linked to the induction of conformational changes in the protein structure, is found in the literature: the flavin adenine dinucleotide (FAD)-linked quinone reductase 2 enzyme gave a reduction in the space group symmetry and structural change upon the binding of chloroquinone (35).…”
Section: Resultsmentioning
confidence: 99%
“…Quinone reductase 2 enzymes are one of known human targets for antimalarial drugs, primaquine and chloroquine. 59,60 The most well-characterised quinone reductase 2 enzyme is human quinone reductase 2 (Nqo2) (PDB 2FGL, 2FGI), which is unique in that it uses dihydronicotinamide riboside (NRH) as a reducing coenzyme rather than NADH or NADPH. 59,60 The structural and sequence alignment of Th-Fre with human quinone reductase 2 shows that Th-Fre is a shorter protein and there is a 30 amino acid insertion at the N terminal of human quinone reductase 2 that forms an extended helix above the flavin domain of opposite monomer (Fig.…”
Section: Crystal Structure and Amino Acid Variability Of Th-halmentioning
confidence: 99%
“…The modulation of the proteasome has also been shown in a yeast homolog quinone reductase Lot6p, which binds to the 20S proteasome and forms a ternary complex with transcriptional factor Yap4p [74, 75]. When binding to a specific inhibitor, the reduction of FAD leads to global changes in the NQO2 structure and stabilization of the active site in an alternate conformation [76], and the conformational switch is consistent with the observation of NQO1 in the redox-dependent regulation of p53 [77]. …”
Section: Puta Is a Flavin Switch Proteinmentioning
confidence: 99%